Imugene Limited

A$0.04As of Sun 8 Nov 2026, 12:00 UTC
ASX:IMUHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (19.16%)
Div yield —
ROE (313.99%)
Biotechnology
Beta (5Y) 2.38
PE TTM —
TSR TTM (90.14%)
Mkt cap A$17.63M
ROIC (156.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0428
18.92%
164.94%
Hold 5|10|8|1|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
42.06%
45.03%
30.45%
23.36%
Revenue$M
1.111
1.153
1.135
1.145
9.22%
9.68%
7.94%
4.49%
Peers (US$12.11M)
Cap (US$)
PE
12.58M
—
Capital
TTM
5Y
10Y
Leveragex
0.839
0.248
0.218
EBIT/Intx
2.285
0.342
0.360
Own earn%
(39.36)
186.86
149.50
Sh yield%
50.40
23.02
22.79
Owners
Insiders/Inst%
2.51
20.67
Short interest%
5.83
SBC / revenue%
5.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–9
$1 testx
0.1
Incr. ROIC%
2